Apr 11, 2022 / 07:00PM GMT
Joseph Robert Stringer - Needham & Company, LLC, Research Division - Senior Analyst
Good afternoon, everyone. Thank you for joining the 21st Annual Needham Healthcare Conference. My name is Joey Stringer, and I'm one of the biotech analysts at Needham & Company. It's my pleasure to introduce our next presenting company, Apellis Pharmaceuticals.
Joining us today from Apellis is Co-Founder, President and CEO, Cedric Francois. For those of you joining on the webcast, if you want to ask a question, please do so at any time. You can submit a question using the chat box at the bottom of your screen.
With that, we'll go ahead and get started. I'll turn it over to Cedric for some opening remarks, and then we'll go ahead and start the chat.
Cedric Francois - Apellis Pharmaceuticals, Inc. - Co-Founder, President, CEO & Director
Well, thank you, Joey, for inviting us, and it's a pleasure to be at this meeting. Still virtually. Soon, we'll do all of this in-person again, I hope. But a few words about Apellis for those of you are less familiar
Apellis Pharmaceuticals Inc at Needham Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot